IKK/NF-κB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis

Journal of Cell Biology

Volumn 180, Issue 4, 2008, Pages 787-802

  Bakkar, Nadine ^a   Wang, Jingxin ^a   Ladner, Katherine J ^a   Wang, Huating ^a   Dahlman, Jason M ^a   Carathers, Micheal ^a   Acharyya, Swarnali ^a   Rudnicki, Michael A ^c   Hollenbach, Andrew D ^d   Guttridge, Denis C ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOD PROTEIN; TRANSCRIPTION FACTOR RELA; TROPOMYOSIN; CHUK PROTEIN, MOUSE; I KAPPA B KINASE; IKBKB PROTEIN, MOUSE; RELA PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOGENESIS; CONTROLLED STUDY; DNA DAMAGE; GENE DOSAGE; HOMEOSTASIS; MITOCHONDRION; MOUSE; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; MYOTUBE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIBIALIS ANTERIOR MUSCLE; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUSCLE CELL; NEWBORN; PRENATAL DEVELOPMENT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSGENIC MOUSE; ULTRASTRUCTURE;

MUS;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; I-KAPPA B KINASE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MUSCLE DEVELOPMENT; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 40849083857     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200707179     Document Type: Article

References (64)

1. Acharyya, S., K.J. Ladner, L.L. Nelsen, J. Damrauer, P.J. Reiser, S. Swoap, and D.C. Guttridge. 2004. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J. Clin. Invest. 114:370-378.
2. Acharyya, S., M.E. Butchbach, Z. Sahenk, H. Wang, M. Saji, M. Carathers, M.D. Ringel, R.J. Skipworth, K.C. Fearon, M.A. Hollingsworth, et al. 2005. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell. 8:421-432.
3. Acharyya, S., S.A. Villalta, N. Bakkar, T. Bupha-Intr, P.M. Janssen, M. Carathers, Z.W. Li, A.A. Beg, S. Ghosh, Z. Sahenk, et al. 2007. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J. Clin. Invest. 117:889-901.
4. Anest, V., J.L. Hanson, P.C. Cogswell, K.A. Steinbrecher, B.D. Strahl, and A.S. Baldwin. 2003. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature. 423:659-663.
5. Baeza-Raja, B., and P. Munoz-Canoves. 2004. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol. Biol. Cell. 15:2013-2026.
6. Baghdiguian, S., M. Martin, I. Richard, F. Pons, C. Astier, N. Bourg, R.T. Hay, R. Chemaly, G. Halaby, J. Loiselet, et al. 1999. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat. Med. 5:503-511.
7. Beg, A.A., W.C. Sha, R.T. Bronson, and D. Baltimore. 1995a. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev. 9:2736-2746.
8. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995b. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376:167-170.
9. Bonizzi, G., M. Bebien, D.C. Otero, K.E. Johnson-Vroom, Y. Cao, D. Vu, A.G. Jegga, B.J. Aronow, G. Ghosh, R.C. Rickert, and M. Karin. 2004. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J. 23:4202-4210.
10. Cai, D., J.D. Frantz, N.E. Tawa Jr., P.A. Melendez, B.-C. Oh, W.R. Lidov, P.O. Hasselgren, W.R. Frontera, J. Lee, D.J. Glass, and S.E. Shoelson. 2004. IKKbeta/NF-kB activation causes severe muscle wasting in mice. Cell. 119:285-298.
11. Canicio, J., P. Ruiz-Lozano, M. Carrasco, M. Palacin, K. Chien, A. Zorzano, and P. Kaliman. 2001. Nuclear factor kappa B-inducing kinase and Ikappa B kinase-alpha signal skeletal muscle cell differentiation. J. Biol. Chem. 276:20228-20233.
12. Chen, S.E., B. Jin, and Y.P. Li. 2007. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am. J. Physiol. Cell Physiol. 292:C1660-C1671.
13. Conejo, R., C. de Alvaro, M. Benito, A. Cuadrado, and M. Lorenzo. 2002. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway. Oncogene. 21:3739-3753.
14. Davis, R.L., H. Weintraub, and A.B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 51:987-1000.
15. Dejardin, E., N.M. Droin, M. Delhase, E. Haas, Y. Cao, C. Makris, Z.W. Li, M. Karin, C.F. Ware, and D.R. Green. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity. 17:525-535.
16. Demicco, E.G., K.T. Kavanagh, R. Romieu-Mourez, X. Wang, S.R. Shin, E. Landesman-Bollag, D.C. Seldin, and G.E. Sonenshein. 2005. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol. Cell. Biol. 25:10136-10147.
17. Doi, T.S., M.W. Marino, T. Takahashi, T. Yoshida, T. Sakakura, L.J. Old, and Y. Obata. 1999. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc. Natl. Acad. Sci. USA. 96:2994-2999.
18. Gerber, A.N., T.R. Klesert, D.A. Bergstrom, and S.J. Tapscott. 1997. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 11:436-450.
19. Gerondakis, S., M. Grossmann, Y. Nakamura, T. Pohl, and R. Grumont. 1999. Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts. Oncogene. 18:6888-6895.
20. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell. 109:S81-S96.
21. Guttridge, D.C., C. Albanese, J.Y. Reuther, R.G. Pestell, and A.S. Baldwin Jr. 1999. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19:5785-5799.
22. Guttridge, D.C., M.W. Mayo, L.V. Madrid, C.-Y. Wang, and A.S. Baldwin Jr. 2000. NF-kB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 289:2363-2366.
23. Hayden, M.S., and S. Ghosh. 2004. Signaling to NF-kB. Genes Dev. 18:2195-2224.
24. Hertlein, E., J. Wang, K.J. Ladner, N. Bakkar, and D.C. Guttridge. 2005. RelA/p65 regulation of IkappaBbeta. Mol. Cell. Biol. 25:4956-4968.
25. Hoberg, J.E., F. Yeung, and M.W. Mayo. 2004. SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. Mol. Cell. 16:245-255.
26. Hu, Y., V. Baud, T. Oga, K.I. Kim, K. Yoshida, and M. Karin. 2001. IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature. 410:710-714.
27. Hunter, R.B., and S.C. Kandarian. 2004. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J. Clin. Invest. 114:1504-1511.
28. Huo, L., and R.C. Scarpulla. 2001. Mitochondrial DNA instability and peri-implantation lethality associated with targeted disruption of nuclear respiratory factor 1 in mice. Mol. Cell. Biol. 21:644-654.
29. Huxford, T., D.B. Huang, S. Malek, and G. Ghosh. 1998. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NFkappaB inactivation. Cell. 95:759-770.
30. Iotsova, V., J. Caamano, J. Loy, Y. Yang, A. Lewin, and R. Bravo. 1997. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3:1285-1289.
31. Kaliman, P., J. Canicio, X. Testar, M. Palacin, and A. Zorzano. 1999. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway. J. Biol. Chem. 274:17437-17444.
32. Karin, M. 1999. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 18:6867-6874.
33. Kumar, A., and A.M. Boriek. 2003. Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J. 17:386-396.
34. Langen, R.C., A.M. Schols, M.C. Kelders, E.F. Wouters, and Y.M. Janssen-Heininger. 2001. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J. 15:1169-1180.
35. Leek, B.T., S.R. Mudaliar, R. Henry, O. Mathieu-Costello, and R.S. Richardson. 2001. Effect of acute exercise on citrate synthase activity in untrained and trained human skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:R441-R447.
36. Lehtinen, S.K., P. Rahkila, M. Helenius, P. Korhonen, and A. Salminen. 1996. Down-regulation of transcription factors AP-1, Sp-1, and NF-kappa B precedes myocyte differentiation. Biochem. Biophys. Res. Commun. 229:36-43.
37. Li, Z.W., S.A. Omori, T. Labuda, M. Karin, and R.C. Rickert. 2003. IKK beta is required for peripheral B cell survival and proliferation. J. Immunol. 170:4630-4637.
38. Liu, T., B. Brouha, and D. Grossman. 2004. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene. 23:39-48.
39. Lyons, C.N., S.C. Leary, and C.D. Moyes. 2004. Bioenergetic remodeling during cellular differentiation: changes in cytochrome c oxidase regulation do not affect the metabolic phenotype. Biochem. Cell Biol. 82:391-399.
40. Monici, M.C., M. Aguennouz, A. Mazzeo, C. Messina, and G. Vita. 2003. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology. 60:993-997.
41. Mourkioti, F., P. Kratsios, T. Luedde, Y.H. Song, P. Delafontaine, R. Adami, V. Parente, R. Bottinelli, M. Pasparakis, and N. Rosenthal. 2006. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J. Clin. Invest. 116:2945-2954.
42. Moyes, C.D., O.A. Mathieu-Costello, N. Tsuchiya, C. Filburn, and R.G. Hansford. 1997. Mitochondrial biogenesis during cellular differentiation. Am. J. Physiol. 272:C1345-C1351.
43. Munz, B., E. Hildt, M.L. Springer, and H.M. Blau. 2002. RIP2, a checkpoint in myogenic differentiation. Mol. Cell. Biol. 22:5879-5886.
44. Naya, F.J., and E. Olson. 1999. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol. 11:683-688.
45. Newman, J.C., and A.M. Weiner. 2005. L2L: a simple tool for discovering the hidden significance in microarray expression data. Genome Biol. 6:R81.
46. Novitch, B.G., D.B. Spicer, P.S. Kim, W.L. Cheung, and A.B. Lassar. 1999. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 9:449-459.
47. Pomerantz, J.L., and D. Baltimore. 2002. Two pathways to NF-kappaB. Mol. Cell. 10:693-695.
48. Pownall, M.E., M.K. Gustafsson, and C.P. Emerson Jr. 2002. Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu. Rev. Cell Dev. Biol. 18:747-783.
49. Rando, T.A., and H.M. Blau. 1994. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125:1275-1287.
50. Rudolph, D., W.C. Yeh, A. Wakeham, B. Rudolph, D. Nallainathan, J. Potter, A.J. Elia, and T.W. Mak. 2000. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14:854-862.
51. Ruocco, M.G., S. Maeda, J.M. Park, T. Lawrence, L.C. Hsu, Y. Cao, G. Schett, E.F. Wagner, and M. Karin. 2005. IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J. Exp. Med. 201:1677-1687.
52. Sabourin, L.A., and M.A. Rudnicki. 2000. The molecular regulation of myogenesis. Clin. Genet. 57:16-25.
53. Sabourin, L.A., A. Girgis-Gabardo, P. Seale, A. Asakura, and M.A. Rudnicki. 1999. Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J. Cell Biol. 144:631-643.
54. Schmitz, M.L., M.A. dos Santos Silva, H. Altmann, M. Czisch, T.A. Holak, and P.A. Baeuerle. 1994. Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation. J. Biol. Chem. 269:25613-25620.
55. Senftleben, U., Y. Cao, G. Xiao, F.R. Greten, G. Krahn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S.C. Sun, and M. Karin. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science. 293:1495-1499.
56. Sil, A.K., S. Maeda, Y. Sano, D.R. Roop, and M. Karin. 2004. IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature. 428:660-664.
57. Sitcheran, R., P.C. Cogswell, and A.S. Baldwin Jr. 2003. NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev. 17:2368-2373.
58. Takeda, K., O. Takeuchi, T. Tsujimura, S. Itami, O. Adachi, T. Kawai, H. Sanjo, K. Yoshikawa, N. Terada, and S. Akira. 1999. Limb and skin abnormalities in mice lacking IKKalpha. Science. 284:313-316.
59. Tanaka, M., M.E. Fuentes, K. Yamaguchi, M.H. Durnin, S.A. Dalrymple, K.L. Hardy, and D.V. Goeddel. 1999. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity. 10:421-429.
60. Wang, H., E. Hertlein, N. Bakkar, H. Sun, S. Acharyya, J. Wang, M. Carathers, R. Davuluri, and D.C. Guttridge. 2007. NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol. Cell. Biol. 27:4374-4387.
61. Weih, F., S.K. Durham, D.S. Barton, W.C. Sha, D. Baltimore, and R. Bravo. 1996. Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent. J. Immunol. 157:3974-3979.
62. Xiao, G., E.W. Harhaj, and S.C. Sun. 2001. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell. 7:401-409.
63. Yamamoto, Y., U.N. Verma, S. Prajapati, Y.T. Kwak, and R.B. Gaynor. 2003. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature. 423:655-659.
64. Zhong, H., R.E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell. 1:661-671.